US 12251470
Lipid nanoparticle formulations
granted A61KA61K31/713A61K9/0019
Quick answer
US patent 12251470 (Lipid nanoparticle formulations) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARBUTUS BIOPHARMA CORPORATION
- Grant date
- Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/713, A61K9/0019, A61K9/1271, A61K9/1272